236 related articles for article (PubMed ID: 37373332)
1. Tenascin-C in Tissue Repair after Myocardial Infarction in Humans.
Matsui K; Torii S; Hara S; Maruyama K; Arai T; Imanaka-Yoshida K
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373332
[TBL] [Abstract][Full Text] [Related]
2. Tenascin-C in cardiac disease: a sophisticated controller of inflammation, repair, and fibrosis.
Imanaka-Yoshida K; Tawara I; Yoshida T
Am J Physiol Cell Physiol; 2020 Nov; 319(5):C781-C796. PubMed ID: 32845719
[TBL] [Abstract][Full Text] [Related]
3. Tenascin-C accelerates adverse ventricular remodelling after myocardial infarction by modulating macrophage polarization.
Kimura T; Tajiri K; Sato A; Sakai S; Wang Z; Yoshida T; Uede T; Hiroe M; Aonuma K; Ieda M; Imanaka-Yoshida K
Cardiovasc Res; 2019 Mar; 115(3):614-624. PubMed ID: 30295707
[TBL] [Abstract][Full Text] [Related]
4. Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair.
Huang CK; Dai D; Xie H; Zhu Z; Hu J; Su M; Liu M; Lu L; Shen W; Ning G; Wang J; Zhang R; Yan X
Circ Res; 2020 Sep; 127(8):953-973. PubMed ID: 32600176
[TBL] [Abstract][Full Text] [Related]
5. Tenascin-C in Heart Diseases-The Role of Inflammation.
Imanaka-Yoshida K
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072423
[TBL] [Abstract][Full Text] [Related]
6. Local production of tenascin-C acts as a trigger for monocyte/macrophage recruitment that provokes cardiac dysfunction.
Abbadi D; Laroumanie F; Bizou M; Pozzo J; Daviaud D; Delage C; Calise D; Gaits-Iacovoni F; Dutaur M; Tortosa F; Renaud-Gabardos E; Douin-Echinard V; Prats AC; Roncalli J; Parini A; Pizzinat N
Cardiovasc Res; 2018 Jan; 114(1):123-137. PubMed ID: 29136112
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive detection of cardiac repair after acute myocardial infarction in rats by 111 In Fab fragment of monoclonal antibody specific for tenascin-C.
Odaka K; Uehara T; Arano Y; Adachi S; Tadokoro H; Yoshida K; Hasegawa H; Imanaka-Yoshida K; Yoshida T; Hiroe M; Irie T; Tanada S; Komuro I
Int Heart J; 2008 Jul; 49(4):481-92. PubMed ID: 18753731
[TBL] [Abstract][Full Text] [Related]
8. Pressure overload-induced right ventricular failure is associated with re-expression of myocardial tenascin-C and elevated plasma tenascin-C levels.
Hessel M; Steendijk P; den Adel B; Schutte C; van der Laarse A
Cell Physiol Biochem; 2009; 24(3-4):201-10. PubMed ID: 19710535
[TBL] [Abstract][Full Text] [Related]
9. Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction.
Imanaka-Yoshida K; Hiroe M; Nishikawa T; Ishiyama S; Shimojo T; Ohta Y; Sakakura T; Yoshida T
Lab Invest; 2001 Jul; 81(7):1015-24. PubMed ID: 11454990
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor cytoplasmic domain exacerbates post-infarct left ventricular remodeling via orchestrating cardiac inflammation and angiogenesis.
Chong SY; Zharkova O; Yatim SMJM; Wang X; Lim XC; Huang C; Tan CY; Jiang J; Ye L; Tan MS; Angeli V; Versteeg HH; Dewerchin M; Carmeliet P; Lam CSP; Chan MY; de Kleijn DPV; Wang JW
Theranostics; 2021; 11(19):9243-9261. PubMed ID: 34646369
[TBL] [Abstract][Full Text] [Related]
11. Comparison of myocardial remodeling between cryoinfarction and reperfused infarction in mice.
Duerr GD; Elhafi N; Bostani T; Ellinger J; Swieny L; Kolobara E; Welz A; Dewald O
J Biomed Biotechnol; 2011; 2011():961298. PubMed ID: 21151617
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic and Immune Cell Cross-Talk Regulates Cardiac Recovery After Experimental Myocardial Infarction.
Houssari M; Dumesnil A; Tardif V; Kivelä R; Pizzinat N; Boukhalfa I; Godefroy D; Schapman D; Hemanthakumar KA; Bizou M; Henry JP; Renet S; Riou G; Rondeaux J; Anouar Y; Adriouch S; Fraineau S; Alitalo K; Richard V; Mulder P; Brakenhielm E
Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1722-1737. PubMed ID: 32404007
[TBL] [Abstract][Full Text] [Related]
13. EMC10 (Endoplasmic Reticulum Membrane Protein Complex Subunit 10) Is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction.
Reboll MR; Korf-Klingebiel M; Klede S; Polten F; Brinkmann E; Reimann I; Schönfeld HJ; Bobadilla M; Faix J; Kensah G; Gruh I; Klintschar M; Gaestel M; Niessen HW; Pich A; Bauersachs J; Gogos JA; Wang Y; Wollert KC
Circulation; 2017 Nov; 136(19):1809-1823. PubMed ID: 28931551
[TBL] [Abstract][Full Text] [Related]
14. Tenascin C promotes valvular remodeling in two large animal models of ischemic mitral regurgitation.
Hamza O; Kiss A; Kramer AM; Trojanek S; Abraham D; Acar E; Nagel F; Tretter VE; Kitzwögerer M; Podesser BK
Basic Res Cardiol; 2020 Dec; 115(6):76. PubMed ID: 33258993
[TBL] [Abstract][Full Text] [Related]
15. Generation of Transgenic Mice that Conditionally Overexpress Tenascin-C.
Yonebayashi S; Tajiri K; Hara M; Saito H; Suzuki N; Sakai S; Kimura T; Sato A; Sekimoto A; Fujita S; Okamoto R; Schwartz RJ; Yoshida T; Imanaka-Yoshida K
Front Immunol; 2021; 12():620541. PubMed ID: 33763067
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction.
de Kleijn DPV; Chong SY; Wang X; Yatim SMJM; Fairhurst AM; Vernooij F; Zharkova O; Chan MY; Foo RSY; Timmers L; Lam CSP; Wang JW
Cardiovasc Res; 2019 Oct; 115(12):1791-1803. PubMed ID: 30830156
[TBL] [Abstract][Full Text] [Related]
17. Successful Inflammation Imaging of Non-Human Primate Hearts Using an Antibody Specific for Tenascin-C.
Ageyama N; Kurosawa H; Fujimoto O; Uehara T; Hiroe M; Arano Y; Yoshida T; Yasutomi Y; Imanaka-Yoshida K
Int Heart J; 2019 Jan; 60(1):151-158. PubMed ID: 30464121
[TBL] [Abstract][Full Text] [Related]
18. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
[TBL] [Abstract][Full Text] [Related]
19. Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy.
Yokokawa T; Sugano Y; Nakayama T; Nagai T; Matsuyama TA; Ohta-Ogo K; Ikeda Y; Ishibashi-Ueda H; Nakatani T; Yasuda S; Takeishi Y; Ogawa H; Anzai T
Eur J Heart Fail; 2016 Apr; 18(4):375-85. PubMed ID: 26763891
[TBL] [Abstract][Full Text] [Related]
20. Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice.
Nishioka T; Onishi K; Shimojo N; Nagano Y; Matsusaka H; Ikeuchi M; Ide T; Tsutsui H; Hiroe M; Yoshida T; Imanaka-Yoshida K
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1072-8. PubMed ID: 20081106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
